Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621126 · ClinicalTrials.gov registry record · NA
Neuromonitoring During the Latarjet Procedure
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01621126: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01621126 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01621126, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
In a study performed by the Harvard Shoulder Service, it has been documented that there is a significant incidence of neurologic complications of the Latarjet procedure for shoulder instability. 5 out of 52 patients had neurologic complaints post-operatively. 3 of these nerve palsies were transient, however 2 had not yet recovered fully at time of latest follow-up and returned to the operating room for exploration and neurolysis of the axillary nerve and brachial plexus. By using intra-operative neuromonitoring to determine exactly when there is a potential nerve injury during the procedure, the investigators will be able to modify what the investigators do at that step of the procedure, in order to decrease or possibly even eliminate the risk of neurologic injury.
Interventions
- DEVICE Intra-operative neuromonitoring (XLTEK/NATUS EP Protektor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621126
The ClinicalTrials.gov registry entry for NCT01621126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intra-operative neuromonitoring (XLTEK/NATUS EP Protektor) is the first listed.
NCT01621126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01621126 about?
NCT01621126 is a clinical study titled "Neuromonitoring During the Latarjet Procedure". In a study performed by the Harvard Shoulder Service, it has been documented that there is a significant incidence of neurologic complications of the Latarjet procedure for shoulder instability. 5 out of 52 patients had neurologic complaints post-operatively. 3 of these nerve palsies were transient,...
What is the current status of trial NCT01621126?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2011-06. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01621126?
The interventions under investigation include: Intra-operative neuromonitoring (XLTEK/NATUS EP Protektor) (DEVICE).
Who is sponsoring clinical trial NCT01621126?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.